Breaking News: Argentina Expands National Vaccination Schedule to Include Gestational Vaccine for Respiratory Syncytial Virus
The Ministry of Health of a provincial region has announced an innovative move in its vaccination strategy, incorporating a vaccine against Respiratory Syncytial Virus (RSV) into its National Vaccination Calendar. Effective January 1, 2025, pregnant women will be targeted to receive this crucial vaccine, timed with the peak RSV activity periods.
The primary goal of this preemptive strike is to shield newborns and infants up to six months old from lower respiratory tract infections caused by the RSV virus. This common pediatric pathogen frequently results in bronchiolitis, a severe respiratory condition in the very young.
Intended for expectant mothers within their 32nd to 36.6th week of gestation, the RSV vaccine is designed to confer indirect protection to these vulnerable infants post-birth. Mothers can receive this vaccine concurrently with other pregnancy-approved vaccinations.
Public health facilities across the province, including hospitals and community health centers, are actively administering the RSV vaccine at regular operational hours. Pregnant women are encouraged to come forward with their national ID (DNI), vaccination record, pregnancy control card, or any documents that verify their gestational age. No medical prescription is required to receive the vaccine.
Join us in embracing this forward-thinking campaign aimed at bolstering infant health and well-being. Stay informed on the latest rounds of vaccinations and health initiatives impacting our community.
Related reading